Ventas Stock Price, News & Analysis

Ventas, Inc. (NYSE: VTR) announced participation in investor meetings at the BMO 2022 Real Estate Summit on May 12, 2022. Management will present and share written materials that may include forward-looking information, available on the Company’s website on the same date. Ventas operates over 1,200 properties across the U.S., Canada, and the UK, focusing on healthcare and real estate driven by the aging population. As an S&P 500 company, it follows a successful long-term strategy emphasizing property diversification, financial strength, and ESG commitments.

Ventas reported Q1 2022 net income of $0.10 per share and normalized FFO of $0.79 per share, benefiting from $33 million in HHS Grants. The company's same-store cash NOI grew 5.8%, with the SHOP segment achieving 14.2% growth driven by nearly 10% revenue growth. Year-to-date, Ventas closed or committed to approximately $500 million in new investments. For Q2 2022, guidance suggests net income per share between ($0.03) and $0.01, and normalized FFO of $0.69 to $0.73. The company expects further improvement in the SHOP segment amidst inflationary pressures.

Ventas, Inc. (NYSE: VTR) has revised its management agreement with Sunrise Senior Living to enhance performance across 92 senior housing communities. The agreement aligns incentives towards Net Operating Income (NOI) growth, particularly as the senior housing industry recovers. Key terms include a new management fee structure focused on NOI, incentive payments for achieving growth targets, and enhanced operational flexibility. While the near-term financial impact is expected to be immaterial, the partnership aims to position Ventas for long-term profitability and success in the evolving market.

Ventas, Inc. (NYSE: VTR) announces the appointment of Bill Grant as Senior Vice President of Investor Relations, effective May 9, 2022. Grant, who has over 20 years of investment management experience, previously served at Morgan Stanley, overseeing $9 billion in client assets and specializing in healthcare real estate investments. His role at Ventas will focus on enhancing investor communication and articulating the company's strategic direction and growth potential, reflecting Ventas's commitment to transparency and shareholder value.

Ventas, Inc. (NYSE: VTR) announced the withdrawal of proxy fight candidate Jonathan Litt from its 2022 Annual Meeting scheduled for April 27, 2022. This follows Land & Buildings' earlier withdrawal of another nominee, Michelle Applebaum. Ventas expressed appreciation for shareholder engagement and highlighted its strong asset portfolio catering to the aging population. The company encourages shareholders to vote 'FOR ALL' nominees on the WHITE proxy card, aiming for continued growth in the senior housing sector.

Land & Buildings Investment Management, a major shareholder of Ventas, Inc. (VTR), has issued a statement regarding its campaign focused on improving the company’s performance. They claim to have received support from many shareholders on identifying existing problems and proposed solutions aimed at restoring Ventas's blue-chip REIT status. However, due to challenges from proxy advisory firms, they are withdrawing their director nomination. Land & Buildings remains a significant shareholder and is keen on the Board's actions to enhance performance.

Ventas, Inc. (NYSE: VTR) will release its Q1 2022 earnings on May 5, 2022, after market close, followed by a conference call on May 6, 2022, at 10:00 a.m. ET. The call is accessible via dial-in or live webcast on the company's Investor Relations website. Ventas, a leading REIT, owns over 1,200 properties across North America and the UK, capitalizing on the growing demand from the aging population. The company focuses on senior living, life sciences, and healthcare real estate, emphasizing diversification and sustainability in its long-term strategy.

Ventas, Inc. (NYSE: VTR) has issued a letter urging shareholders to vote "FOR ALL" of its directors using the WHITE proxy card in connection with the upcoming virtual annual meeting on April 27, 2022. The independent directors express confidence in the Board's performance and emphasize their commitment to shareholder value, highlighting their management of over 1,200 properties. They advocate for re-election of Presiding Director Denny Shelton, citing his operational expertise and successful history in the healthcare sector. Shareholders are encouraged to read the definitive proxy statement for detailed information.